Patent · US Expired

Pyrido[1,2,3-D,E] [1,3,4]benzoxadiazine derivatives

US5508278A · kind A · utility

6Cited by

4References

9Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Thomas Jaetsch · Cologne, DE
Burkhard Mielke · Leverkusen, DE
Uwe Petersen · Leverkusen, DE
Thomas Philipps · Cologne, DE
Thomas Schenke · Odenthal, DE
Klaus-Dieter Bremm · Recklinghausen, DE
Rainer Endermann · Wuppertal, DE
Karl G. Metzger · Wuppertal, DE
Martin Scheer · Wuppertal, DE
Michael Stegemann · Lenexa, US
Heinz-Georg Wetzstein · Leverkusen, DE

Key dates

Filing date	Aug 26, 1994
Grant date	Apr 16, 1996
Priority date	—
Expiry date	Aug 26, 2014

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Novel bactericidal pyrido[1,2,3-d,e,][1,3,4]benzoxadiazine derivatives of the formula (I) ##STR1## in which R.sup.1 is hydrogen or C.sub.1 -C.sub.4 -alkyl optionally substituted by hydroxyl or halogen, PA1 R.sup.2 independently of R.sup.1 is hydrogen or methyl, PA1 R.sup.3 is hydrogen or C.sub.1 -C.sub.4 -alkyl, PA1 R.sup.4 is hydrogen, C.sub.1 -C.sub.4 -alkyl optionally substituted by hydroxyl, methoxy, amino, methylamino or dimethylamino, or (5-methyl-2-oxo-1,3-dioxol-4-yl)-methyl, PA1 X.sup.1 is hydrogen or halogen and PA1 Z is a radical of the structure ##STR2##

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.